Merck & Co. Inc. said on Monday it has applied for U.S. emergency use authorization for its tablet to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease.
Coast guard looks to squeeze more years from oldest ship2,000 days in solitary and counting: Federal reforms to segregation flawed, say prisoner rights advocatesWhat it's like to quit your banking job and become a successful baseball writerHidden camera reveals how bank employees mislead and upsell on pricey credit card insuranceDennis Oland's murder retrial in 2011 killing of father set to begin
0 comments:
Post a Comment